4.2 Article

Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry

Giuseppe Limongelli et al.

Summary: This study investigates the capacity of the rare disease healthcare network in Campania to diagnose patients with rare diseases during the Covid-19 outbreak, and sheds light on problematic diagnoses during this period. The results show that the prevalence of new diagnoses of rare disease was significantly lower during the outbreak, and various issues such as lack of diagnostic resources and guidelines were identified.

JOURNAL OF PUBLIC HEALTH (2022)

Article Genetics & Heredity

It seems like COVID-19 now is the only disease present on Earth: living with a rare or undiagnosed disease during the COVID-19 pandemic

Meghan C. Halley et al.

Summary: This study investigated the specific impacts of the COVID-19 pandemic on patients with rare and undiagnosed diseases (RUDs), revealing barriers to essential healthcare, exacerbated physical and mental health challenges, and reduced access to educational and therapeutic services. Urgent measures are needed to address these challenges during and after the pandemic.

GENETICS IN MEDICINE (2021)

Review Medicine, General & Internal

Histiocytosis

Jean-Francois Emile et al.

Summary: Histiocytoses are rare disorders characterized by infiltration of various organs by myeloid cells, with diagnosis often delayed due to low incidence and diverse clinical manifestations. Somatic mutations in genes activating the MAP kinase pathway are commonly found in biopsy specimens, and targeted therapies with BRAF or MEK inhibitors have revolutionized treatment but challenges such as duration and prevention of neurological sequelae remain.

LANCET (2021)

Review Public, Environmental & Occupational Health

Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures

Sanjana Fatema Chowdhury et al.

Summary: The COVID-19 pandemic has made the lives of patients with rare diseases more vulnerable and marginalized, while clinicians and researchers working on rare genetic diseases are facing extra challenges. Despite the obstacles, telehealth and virtual consultations have provided hope for rare disease patients.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Oncology

Pituitary Imaging Abnormalities and Related Endocrine Disorders in Erdheim-Chester Disease

Skand Shekhar et al.

Summary: The study found that approximately 47.5% of patients with ECD had abnormal pituitary imaging, which was associated with panhypopituitarism and diabetes insipidus. This highlights the importance of routine imaging and assessment of hypothalamic-pituitary endocrine function in ECD patients.

CANCERS (2021)

Review Hematology

Erdheim-Chester disease

Julien Haroche et al.

Editorial Material Medicine, General & Internal

The Untold Toll - The Pandemic's Effects on Patients without Covid-19

Lisa Rosenbaum

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Prevalence of Hypothyroidism in Patients With Erdheim-Chester Disease

Skand Shekhar et al.

JAMA NETWORK OPEN (2020)

Article Hematology

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

Juvianee I. Estrada-Veras et al.

BLOOD ADVANCES (2017)

Review Medicine, General & Internal

Fever of Unknown Origin: A Clinical Approach

Burke A. Cunha et al.

AMERICAN JOURNAL OF MEDICINE (2015)

Article Infectious Diseases

Erdheim-Chester disease: A rare cause of recurrent fever of unknown origin mimicking lymphoma

Anusiyanthan Mariampillai et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)